Reduced Susceptibility to Antiseptics Is Conferred by Heterologous Housekeeping Genes
Metagenomics Helps Identify Oral Microbiome Resistance Mechanisms
Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
Cell-Based, Cell-Free Patches for Cardio Repair
Cardiologists May Now Feel Differently about Quick Patch Ups
RNAi Therapeutics: To the Liver ... and Beyond
RNAi Therapy Components Are Surviving Degradation, Staying Potent, and Reaching More Targets Than Ever
For full access to this article login to GEN Select now.
Bending the Cost and Time Curve of Drug Development through the Use of Biomarkers
- The right biomarker can make all the difference in a drug-development program, allowing a clinical trial to enroll a smaller patient population, lowering costs, and shortening timelines. As much as the right biomarker might be desired, it might not exist. It might need to be discovered and developed. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.